suppressor is haploinsufficient for mammary gland development and epithelial cell polarity Pratima Basak1,2,3,4, Rachelle Dillon1, Heather Leslie1, Afshin Raouf1,3,4 and Michael R. A. Mowat1,2* Background: Deleted in Liver Cancer 1 (Dlc1) is a tumor suppressor gene, which maps to human chromosome 8p21-22 and is found frequently deleted in many cancers including breast cancer. The promoter of the remaining allele is often found methylated. The Dlc1 gene encodes a RhoGAP protein that regulates cell proliferation, migration and inhibits cell growth and invasion when restored in Dlc1 deficient tumor cell lines. This study focuses on determining the role of Dlc1 in normal mammary gland development and epithelial cell polarity in a Dlc1 gene trap...
Background: Deleted in liver cancer 2 (DLC2) gene, a putative tumour suppressor gene, encodes a Rho ...
Background/Aims: The chromosome locus 3p21.3 is a "hot-spot" for chromosomal aberrations and loss of...
Breast cancer is a group of clinically, histopathologically and molecularly heterogeneous diseases, ...
Epithelial cell–cell contacts are mediated by E-cadherin interactions, which are regulated by the ba...
Full list of author information is available at the end of the articleEpithelial ovarian cancer (EOC...
The deleted in liver cancer 1 (DLC-1) gene encodes a GTPase activating protein that acts as a negati...
Contains fulltext : 98031.pdf (publisher's version ) (Open Access)Differentiated m...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Human chromosomal region 13q14 is a deletion hotspot in prostate cancer, multiple mye-loma, and chro...
Deleted in Liver Cancer-1 (DLC1), a member of the RhoGAP family of proteins, functions as a tumor su...
Background: Deleted in liver cancer (DLC) is a family of tumour suppressors that plays a critical ro...
Breast cancer is considered to display a high degree of intratumor heterogeneity, without any obviou...
Purpose: Tumor suppressor genes participate in a variety of critical and highly conserved cell funct...
Identification of tumor suppressor genes (TSG) silenced by methylation uncovers mechanisms of tumori...
Background Aberrant expression of tumor suppressor genes may correspond to the abnormal cell devel-o...
Background: Deleted in liver cancer 2 (DLC2) gene, a putative tumour suppressor gene, encodes a Rho ...
Background/Aims: The chromosome locus 3p21.3 is a "hot-spot" for chromosomal aberrations and loss of...
Breast cancer is a group of clinically, histopathologically and molecularly heterogeneous diseases, ...
Epithelial cell–cell contacts are mediated by E-cadherin interactions, which are regulated by the ba...
Full list of author information is available at the end of the articleEpithelial ovarian cancer (EOC...
The deleted in liver cancer 1 (DLC-1) gene encodes a GTPase activating protein that acts as a negati...
Contains fulltext : 98031.pdf (publisher's version ) (Open Access)Differentiated m...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Human chromosomal region 13q14 is a deletion hotspot in prostate cancer, multiple mye-loma, and chro...
Deleted in Liver Cancer-1 (DLC1), a member of the RhoGAP family of proteins, functions as a tumor su...
Background: Deleted in liver cancer (DLC) is a family of tumour suppressors that plays a critical ro...
Breast cancer is considered to display a high degree of intratumor heterogeneity, without any obviou...
Purpose: Tumor suppressor genes participate in a variety of critical and highly conserved cell funct...
Identification of tumor suppressor genes (TSG) silenced by methylation uncovers mechanisms of tumori...
Background Aberrant expression of tumor suppressor genes may correspond to the abnormal cell devel-o...
Background: Deleted in liver cancer 2 (DLC2) gene, a putative tumour suppressor gene, encodes a Rho ...
Background/Aims: The chromosome locus 3p21.3 is a "hot-spot" for chromosomal aberrations and loss of...
Breast cancer is a group of clinically, histopathologically and molecularly heterogeneous diseases, ...